Omnicell Announces Financial Results for First Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Omnicell (OMCL) Tops Q1 EPS by 17c, Revenues Beat; Offers FY21 EPS/Revenues Mid-Point Outlook Above Consensus, Offers 2Q Revs. View Above Est.
April 29, 2021 4:36 PM EDTOmnicell (NASDAQ: OMCL) reported Q1 EPS of $0.83, $0.17 better than the analyst estimate of $0.66. Revenue for the quarter came in at $251.84 million versus the consensus estimate of $246.7 million.
We delivered an exceptionally strong first quarter, exceeding our first quarter guidance and achieving record revenue for the quarter, said Randall Lipps, Chairman, President, Chief Executive Officer, and founder of Omnicell. We continue to make tremendous progress advancing the vision of the autonomous pharmacy, and we continue to see robust and growing demand for our... More
